Retiree spending sits at the heart of many consumer and healthcare trends, and a proposed change to Social Security cost of living adjustments could reshape that flow of money. If benefits eventually track the higher of CPI-W or CPI-E from 2027 to 2036, some companies exposed to retiree demand may see a different backdrop for revenue, dividends, and capital allocation. This article walks through three stocks from the Retiree Consumer Spending Beneficiaries screener that appear closely tied to this theme, and it explains why some investors might see them as potential opportunities or prefer to stay on the sidelines.

Charter Hall Group (ASX:CHC)

Overview: Charter Hall Group is an Australian property investment and funds management company that runs and manages a broad mix of office, industrial and logistics, retail and social infrastructure assets for investors. It uses its real estate expertise to source, develop and operate properties while aiming to create value for both tenants and investment partners.

Operations: Charter Hall Group generates A$433.7m from Funds Management, A$387.1m from Property Investments and A$90.3m from Development Investments, with all reported revenue of A$860.7m coming from Australia.

Market Cap: A$11.0b

Charter Hall Group sits at the crossroads of property, retiree housing and income focused investing, which makes the Social Security COLA proposal especially interesting. Higher retiree income could support demand for its social infrastructure and related assets. A growing funds management platform and a high quality earnings profile mean the story has more than one potential growth lever. At the same time, heavy exposure to office and retail, reliance on external borrowing and leadership changes such as the recent Chief Investment Officer departure keep risk on the table. There is also a wide gap to some fair value estimates and a history of dividend payments, so this is a stock that many investors may want to understand more fully before deciding where they stand.

Charter Hall Group’s mix of property income and funds management can look appealing, yet the real story may sit in how its earnings quality stacks up against its current price. Before you decide it is either too complex or too simple, review the DCF valuation analysis for Charter Hall Group to see what the market might be missing.

Janus Living (JAN)

Overview: Janus Living is a U.S. REIT based in Denver that owns and operates senior housing communities through RIDEA structures, focusing entirely on private pay residents rather than government reimbursement. Its 34 communities, with 10,422 units as of December 31, 2025, are concentrated in major retirement markets across 10 states, especially Florida and Texas.

Operations: Janus Living generates US$655.4m in revenue from senior housing across the United States.

Market Cap: US$8.6b

Janus Living sits in the path of a potential shift in retiree income if higher Social Security COLAs are adopted, since it already runs a large private pay senior housing platform that is closely tied to day to day living expenses. Revenue of US$200.35m in Q1 2026, double digit revenue growth, ambitious earnings forecasts and inclusion in multiple Russell indices have pushed it onto more institutional radars. At the same time, recent equity raises and a 1.93% dividend that is not yet covered by free cash flow point to meaningful financial risk. The company is still loss making and led by a very new management team, which highlights a gap between the growth story and the cash generation that investors may want to examine carefully.

Janus Living’s accelerating revenue and index inclusion have many investors focused on growth; however, the gap between its story and free cash flow is just as important. Get the full picture in the analyst forecasts for Janus Living

NIOX Group (AIM:NIOX)

Overview: NIOX Group is a UK based medical technology company that designs, develops, and sells NIOX VERO, a handheld device and consumables that help doctors diagnose, monitor, and manage asthma and COPD by measuring exhaled nitric oxide levels. Its products are used worldwide in clinics and hospitals to support ongoing care for patients with chronic respiratory conditions.

Operations: NIOX Group generates £48.7m in revenue from its NIOX branded asthma and COPD testing products, with sales spread across Asia Pacific (£18.3m), the EU excluding the UK (£12.4m), the United States (£12m), the United Kingdom (£3.9m), and the rest of the world (£2.1m).

Market Cap: £256.6m

NIOX Group operates at the intersection of respiratory diagnostics and ageing populations, which could matter if higher Social Security COLAs eventually boost healthcare spending by retirees with chronic conditions. The company reports a 14.4% net margin and analyst expectations for ongoing earnings growth. Some valuation models suggest the share price is trading below estimated fair value, although the current P/E still reflects a premium. This combination may appeal to investors who see a long runway for asthma and COPD testing in primary care settings. However, modest ROE, a dividend that is not well covered by earnings and reliance on external borrowing mean the balance of potential reward and risk is not straightforward, and investors who look closer may find more to consider than the headline growth story implies.

NIOX Group’s premium P/E and respiratory focus may only tell half the story. See how the balance between earnings power, valuation signals, and hidden risks lines up in the analysis report for NIOX Group

The three stocks covered here are only a starting point. The full Retiree Consumer Spending Beneficiaries screener surfaces 15 more companies with equally compelling retiree spending stories that you have not seen yet. Use Simply Wall St to identify and analyze the specific catalysts, dividend profiles, and retiree driven narratives discussed here so you can focus on the highest conviction ideas for your watchlist.

Take Control of Your Investment Journey

If Janus Living or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Today

Stock stories move fast and the strongest candidates can shift from under the radar to flying higher before most investors notice. Scan these fresh ideas while it matters and consider how they might fit your approach.

• Spot resilient companies that aim to protect capital while the market swings by scanning the 9 resilient stocks with low risk scores curated specifically to prioritize downside protection and steadier compounding potential.
• Track early momentum in miners before sentiment becomes crowded by reviewing the curated 32 elite gold producer stocks focused on potential shifts in production, costs, and investor attention.
• Explore the next wave of infrastructure demand with a focused list built around grid upgrades and electrification using the 36 power grid technology and infrastructure stocks before these projects fully reach mainstream coverage.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.